COVID-19: Public Health, Research and Careers at the Frontline
This COVID-19 trial will evaluate different treatments such as antiretroviral drugs and antimalarial drugs for COVID-19 patients in hospital. It is part of a multinational initiative called the Solidarity Trial which is being coordinated by the World Health Organization and supported by the Canadian Institutes of Health Research in an unprecedented level of global collaboration. Dr. Murthy studies severe infections and how best to manage critically ill patients. Presented by Dr. Srinivas Murthy, Investigator, BC Children's Hospital; Clinical Associate Professor, Department of Pediatrics, Faculty of Medicine, UBC. (2020)
A new study led by researchers from the BC Injury Research and Prevention Unit found girls in rural B.C. communities with poor access to local mental health services are at the highest risk of intentionally poisoning themselves. The most common substance used was non-opioid painkillers and the second most common substance used was medication for anxiety and depression.
Dr. Pascal Lavoie and his team compared the immune responses of babies to those of COVID-19-negative adults from Metro Vancouver. The antibody reactivity to SARS-CoV-2 in almost all of these adults was up to 100-fold higher compared to the infants at second blood sera collection. The researchers estimate that between 90-99 per cent of adults have positive antibody reactivity to SARS-CoV-2 antigens.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.